ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RGC vs PM // 10Y YIELD & FRED MACRO BETA

Regencell Bioscience Holdings Limited (NASDAQ) VS. Philip Morris International Inc (NYSE) • 15-METRIC TALLY: RGC 0 — PM 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGC VS. PM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RGC PM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 45.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — 21.7x — TIE /valuation <GO>
Free Cash Flow Yield -0.10% 3.28% -3.38 PM /fcf-yield <GO>
Operating Margin — 36.60% — TIE /operating-margins <GO>
Net Profit Margin — 27.90% — TIE /net-margins <GO>
Revenue Growth (YoY) — 7.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.65% -2.65 PM /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.52 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 PM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.1 63.9 -19.80 PM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — 0.93 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 26.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.40B $324.98B -$321.58B PM /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RGC REV PM REV RGC GROSS % PM GROSS % RGC FCF PM FCF
FY 2025 $0 $40.65B — 67.1% -$3.3M $10.66B
FY 2024 $0 $37.88B — 64.8% -$4.0M $10.77B
FY 2023 $0 $35.17B — — -$5.0M $7.62B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGC // BETA —
PM // BETA 0.93